Global Contract Pharmaceutical Manufacturing Market Growth (Status and Outlook) 2025-2031

Global Contract Pharmaceutical Manufacturing Market Growth (Status and Outlook) 2025-2031

The global Contract Pharmaceutical Manufacturing market size is predicted to grow from US$ 95750 million in 2025 to US$ 136750 million in 2031; it is expected to grow at a CAGR of 6.1% from 2025 to 2031.

Contract Pharmaceutical Manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and son on which required for pharmaceutical manufacturing.

Global Contract Pharmaceutical Manufacturing key players include Catalent, Thermo Fisher Scientific, Lonza, Boehringer Ingelheim, Fareva, etc. Global top five players hold a share about 10%.

North America is the largest market, with a share about 30%, followed by Europe and China, having a total share about 30 percent.

In terms of product, API is the largest segment, with a share about 75%. And in terms of application, the largest application is Large Enterprise, followed by Small Medium Enterprise.

LPI (LP Information)' newest research report, the “Contract Pharmaceutical Manufacturing Industry Forecast” looks at past sales and reviews total world Contract Pharmaceutical Manufacturing sales in 2024, providing a comprehensive analysis by region and market sector of projected Contract Pharmaceutical Manufacturing sales for 2025 through 2031. With Contract Pharmaceutical Manufacturing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Contract Pharmaceutical Manufacturing industry.

This Insight Report provides a comprehensive analysis of the global Contract Pharmaceutical Manufacturing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Contract Pharmaceutical Manufacturing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Contract Pharmaceutical Manufacturing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Contract Pharmaceutical Manufacturing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Contract Pharmaceutical Manufacturing.

This report presents a comprehensive overview, market shares, and growth opportunities of Contract Pharmaceutical Manufacturing market by product type, application, key players and key regions and countries.

Segmentation by Type:
Oral
Injectable
API
Other

Segmentation by Application:
Large Enterprise
Small Medium Enterprise

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Catalent
DPx
Lonza
Piramal Healthcare
Aenova
Jubilant
Famar
Boehringer Ingelheim
Fareva Holding
AbbVie
Nipro Corp
Vetter
Sopharma
DPT Laboratories
Recipharm
NextPharma
Dishman
Aesica

Please note: The report will take approximately 2 business days to prepare and deliver.